Research and Markets : Stakeholder Insight: Local and Locally Advanced Prostate Cancer
Posted on: Tuesday, 23 November 2004, 15:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c9908) has announced the addition of Stakeholder Insight: Local and Locally Advanced Prostate Cancer to their offering
Prostate cancer is the most common male malignancy in Western countries.
Increasing usage of screening and changes in treatment practice means companies will have to adapt to exploit the market. Local and Locally Advanced Prostate Cancer Insight details physician opinion of currently available products and disease management practice and what they require in the future.
Scope
Quantitative treatment data from over 440 physicians: 60 from Japan, France, Germany, Italy, Spain and the UK, and 80 from the US
Qualitative feedback on key findings and future trends in the treatment of prostate cancer and the management of disease and treatment side effects
Coverage of the hot topics affecting current treatment patterns, from the impact of IMRT on brachytherapy to the increasing use of bisphosphonates
Highlights
AstraZeneca is promoting Casodex monotherapy heavily in non-metastatic disease as an alternative to an LHRH agonist. Approval for Casodex monotherapy has been delayed in some markets, but physicians are already prescribing off-label, especially in patients with dementia, a condition that can be exacerbated by the use of LHRH agonists.
Prostate cancer is the most common male malignancy in Western countries. Increased screening and changes in treatment practice means companies will have to adapt to exploit the market. Prostate Cancer Insight details physician opinion of currently available products and disease management practice and requirements in the future.
This report is designed to:
Identify hot topics and key issues for practicing prostate cancer specialists the questions they really want answered
Plan product development to fill prostate cancer market niches as defined by practicing physicians
For more information visit http://www.researchandmarkets.com/reports/c9908
Source: Business Wire
Related Articles
- Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution
- Community Care Physicians Selects Allscripts Practice Management System for 190 Physicians in New York Capitol Region
- Park City Healthcare Chooses iMedica Electronic Health Record (EHR) and Practice Management (PM) Technology
- Stratus Technologies and Pulse Systems, Inc. Partner to Serve EHR and Practice Management Market
- ZoomMed's ZRx Prescriber is Chosen By MCI Medical Clinics Inc., The Largest Provider of Practice Management Services to Family Physicians in Canada
- Misys Healthcare Advocates Change in EMR and Practice Management Solutions for Small Physician Practices
- Novant Health Selects Allscripts Practice Management System for 800 Physicians
- Allscripts HealthMatics(R) EHR and Practice Management System Accepted By Physician Specialty Groups
- HealthCare Partners Selects Allscripts Practice Management System for Affiliated Physician Groups
- Alzheimer's Disease: The Physician's Guide to Practical Management
 |
 |
User Comments (0)
RSS Feeds